Evidence map›Paper›PMID 37137839›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Advances in imaging diagnosis of mixed-type liver cancer].

Y L Chen, W P Wang

Open access · greenAbstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Y L ChenDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
W P WangDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China Shanghai Institute of Medical Imaging, Shanghai 200032, China.
Zhongshan Hospital · CN

Funding

Shanghai Municipal Key Clinical Specialty shslczdzk03501
6 · The paper itself

Abstract

Mixed-type liver cancer is a rare kind of primary malignant liver tumor with risk factors similar to those of hepatocellular carcinoma and intrahepatic cholangiocarcinoma, although treatment methods and prognosis differ. An early imaging diagnosis is helpful in adopting appropriate treatment strategies for mixed-type liver cancer. Since mixed-type liver cancer contains different proportions of hepatocellular carcinoma and cholangiocarcinoma in the same lesion, imaging manifestations may vary. This paper reviews the recent literature reports, imaging characteristics, and the latest imaging diagnostic techniques in relation to the imaging diagnosis of mixed-type liver cancer.

Indexed as

Bile Duct NeoplasmsCarcinoma, HepatocellularCholangiocarcinomaLiver NeoplasmsBile Ducts, IntrahepaticDiagnostic ImagingHumansCombined hepatocellular cholangiocarcinomaDiagnosisImaging examinationLiver cancer

Identifiers

PMID37137839
PMCPMC12814284
OpenAlexW4368361317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.